Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Online information and support needs of women with advanced breast cancer: a qualitative analysis.
Kemp E, Koczwara B, Butow P, Turner J, Girgis A, Schofield P, Hulbert-Williams N, Levesque J, Spence D, Vatandoust S, Kichenadasse G, Roy A, Sukumaran S, Karapetis CS, Richards C, Fitzgerald M, Beatty L. Kemp E, et al. Among authors: kichenadasse g. Support Care Cancer. 2018 Oct;26(10):3489-3496. doi: 10.1007/s00520-018-4206-1. Epub 2018 Apr 24. Support Care Cancer. 2018. PMID: 29693203
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Sweeney CJ, Martin AJ, Stockler MR, Begbie S, Cheung L, Chi KN, Chowdhury S, Frydenberg M, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Vera-Badillo F, Williams SG, Winter D, Yip S, Zhang AY, Zielinski RR, Davis ID; ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Sweeney CJ, et al. Lancet Oncol. 2023 Apr;24(4):323-334. doi: 10.1016/S1470-2045(23)00063-3. Lancet Oncol. 2023. PMID: 36990608 Clinical Trial.
Abiraterone in metastatic prostate cancer.
Kichenadasse G, Karapetis C. Kichenadasse G, et al. N Engl J Med. 2013 Apr 11;368(15):1457. doi: 10.1056/NEJMc1301594. N Engl J Med. 2013. PMID: 23574134 No abstract available.
Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
Patel GS, Jain K, Kumar R, Strickland AH, Pellegrini L, Slavotinek J, Eaton M, McLeay W, Price T, Ly M, Ullah S, Koczwara B, Kichenadasse G, Karapetis CS. Patel GS, et al. Among authors: kichenadasse g. Support Care Cancer. 2014 Jan;22(1):121-8. doi: 10.1007/s00520-013-1941-1. Epub 2013 Sep 5. Support Care Cancer. 2014. PMID: 24005884 Clinical Trial.
Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years.
Padman S, Lee J, Kumar R, Slee M, Hakendorf P, Richards A, Koczwara B, Kichenadasse G, Sukumaran S, Roy A, Vatandoust S, Karapetis CS. Padman S, et al. Among authors: kichenadasse g. Support Care Cancer. 2015 Mar;23(3):861-9. doi: 10.1007/s00520-014-2423-9. Epub 2014 Sep 16. Support Care Cancer. 2015. PMID: 25223350
135 results